ARTV

COM:ARTIVABIO

Artiva Biotherapeutics

Stock

USD

Last Close

10.88

22/11 21:00

Market Cap

105.10M

Beta: -

Volume Today

36.36K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '21	Dec '22	Dec '23
revenue	2.00M -	4.93M 146.30%	33.49M 579.21%
cost of revenue
gross profit	2.00M -	4.93M 146.30%	33.49M 579.21%
selling and marketing expenses
general and administrative expenses	12.86M -	20.78M 61.50%	13.91M 33.04%
selling general and administrative expenses	12.86M -	20.78M 61.50%	13.91M 33.04%
research and development expenses	42.41M -	43.98M 3.71%	50.25M 14.25%
other expenses	-18.55M -	200K 101.08%	-195K 197.50%
cost and expenses	55.27M -	64.76M 17.16%	64.16M 0.92%
operating expenses	55.27M -	64.76M 17.16%	64.16M 0.92%
interest expense
ebitda	-71.58M -	-58.67M 18.03%	-29.11M 50.38%
operating income	-53.27M -	-59.83M 12.31%	-30.67M 48.74%
depreciation and amortization	248K -	1.16M 366.94%	2.27M 95.68%
total other income expenses net	-18.55M -	200K 101.08%	512K 156%
income before tax	-71.83M -	-58.34M 18.78%	-27.62M 52.65%
income tax expense	-18.55M -	53K 100.29%	72K 35.85%
net income	-71.83M -	-58.39M 18.71%	-27.70M 52.57%
weighted average shs out	17.58M -	17.58M 0%	17.58M 0%
weighted average shs out dil	17.58M -	17.58M 0%	17.58M 0%
eps	-4.08 -	-3.32 18.63%	-1.58 52.41%
epsdiluted	-4.08 -	-3.32 18.63%	-1.58 52.41%

All numbers in USD (except ratios and percentages)